From: Assessing migraine patients with multifocal pupillographic objective perimetry
 | Subjects (n = 38) | Controls (n = 24) |
---|---|---|
Age (mean ± SD) | 42.0 ± 16.5 | 39.2 ± 15.2 |
Male: Female | 1: 1.8 | 1: 1.5 |
Migraine type after BP or YP | – | |
 •With aura | 26 (72%) | |
 •Without aura | 15 (42%) | |
Mean age of onset (years) (±SD) | 17.8 ± 9.11 | – |
Mean disease duration (years) (±SD) | 24.3 ± 16.7 | – |
Treatment | – | |
 •Preventative | 8 (22%) | |
 •During attacks |  | |
  Over the counter | 25 (69%) | |
  Triptans | 14 (39%) | |
  Opioids | 13 (36%) | |
  Ergot | 2 (6%) | |
Mean attacks per month (±SD) | 2.62 ± 5.17 | – |
Mean headache duration (hours) (±SD) | 11.75 ± 16.5 | – |
Trigger | – | |
 •Light | 15 (41%) | |
 •Other | 32 (88%) | |
Photophobia | 34 (94%) | – |